Picture EBD Group Startup Spotlight at BIO-Europe 2023 650x100px

News > All

Total search results: 1154 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Aboleris Pharma. (9/18/23). "Press Release: Aboleris Pharma Announces €27 Million in Series A Financing to Advance its Novel Treatment Paradigm for Autoimmune and Inflammatory Diseases". Gosselies. 2023-09-18
Lauxera Capital Partners. (9/12/23). "Press Release: Lauxera Capital Partners Invests €17 Million in Swedish Regenerative Medicine Leader BioLamina AB". Paris & San Francisco, CA. 2023-09-12
Qiagen N.V.. (9/11/23). "Press Release: Qiagen Launches API to Streamline Access to World-leading Biomedical Data for AI Integration". Venlo & Redwood City, CA. 2023-09-11
Proteros Biostructures GmbH. (9/6/23). "Press Release: Proteros Biostructures and Orion Pharma Agree on a Long-term Multi-target Collaboration". Martinsried. 2023-09-06
Illumina, Inc.. (9/5/23). "Press Release: Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer". San Diego, CA. 2023-09-05
BioInnovation Institute (BII). (9/4/23). "Press Release: Six Companies Enter BioInnovation Institute’s Venture House Program Receiving Additional Financial Support". 2023-09-04
CEPI. (8/29/23). "Press Release: CEPI and University of Oxford to Accelerate Vaccine Development against Disease X". Oslo & Oxford. 2023-08-29
Bico Group AB. (8/21/23). "Press Release: Bico Announces Goodwill Impairment Predominantly Due to Increased WACC, and Write-downs of Assets". 2023-08-21
Bico Group AB. (8/21/23). "Press Release: Maria Forss Is Appointed New President and CEO of Bico Group AB (publ)". 2023-08-21
BioLamina AB. (8/16/23). "Press Release: BioLamina Announces Appointment of New Management Team Members". 2023-08-16
Novo Nordisk A/S. (8/10/23). "Press Release: Novo Nordisk to Acquire Inversago Pharma to Develop New Therapies for People Living with Obesity, Diabetes and other Serious Metabolic Diseases". Bagsværd & Montreal. 2023-08-10
Bactolife A/S. (8/8/23). "Press Release: Bactolife Raises EUR 30 Million in Series A Financing". Copenhagen. 2023-08-08
IO Biotech, Inc.. (8/7/23). "Press Release: IO Biotech, Inc. Announces $75 Million Private Placement Financing". New York, NY. 2023-08-07
Bico Group AB. (8/3/23). "Press Release: Bico Divests Berlin Property for a Total of EUR 21m". 2023-08-03
Biovian Oy. (7/26/23). "Press Release: Biovian Announces over €50 Million Investment in Manufacturing Facility in Turku, Finland". 2023-07-26
Golgi Neurosciences S.r.l.. (7/25/23). "Press Release: Golgi Neurosciences and Breye Therapeutics Announce Successful Closing of P2X7 Receptor Antagonist program transfer". Milan & Copenhagen. 2023-07-25
Accession Therapeutics Ltd.. (7/19/23). "Press Release: Chief Business Officer Appointed at Accession Therapeutics as Company Prepares for Clinical Trials". Oxford. 2023-07-19
High-Tech Gründerfonds Management GmbH. (7/14/23). "Press Release: Pioneering Research Projects at the 8th Life Science Pitch Day at the IZB". Martinsried. 2023-07-14
BioGeneration Ventures B.V.. (7/13/23). "Press Release: BioGeneration Ventures Closes BGV Fund V at €150 Million". Naarden. 2023-07-13
Golgi Neurosciences S.r.l.. (7/5/23). "Press Release: Golgi Neurosciences, a Unique Incubator to Combat Neurodegenerative Disorders, Starts Operating". Milan. 2023-07-05
NorthX Biologics. (7/3/23). "Press Release: NorthX Biologics, a Leading Nordic Development and Manufacturing Organisation Announces Acquisition of a Biologics Manufacturing Unit from Valneva". Matfors. 2023-07-03
EBD Group. (6/27/23). "Press Release: BIO-Europe 2024 Is Going to Stockholm". Munich. 2023-06-27
EQT AB. (6/21/23). "Press Release: EQT Private Equity to Sell Ellab, Following Transformation into a Leading Validation & Monitoring Provider for the Biotech and Pharmaceutical Industries". 2023-06-21
Thermosome GmbH. (6/20/23). "Press Release: Thermosome Announces Participation in IMAGIO Consortium to Improve Cancer Treatment". Munich. 2023-06-20
Qiagen N.V.. (6/13/23). "Press Release: Danish National Genome Center Selects Qiagen for Variant Interpretation in Oncology Genome Sequencing". Venlo & Redwood City, CA. 2023-06-13
BC Platforms AG. (6/1/23). "Press Release: BC Platforms Acquires 4Pharma, a Leading International Provider of Medical Research Data and Analytics Services for Global Clinical Trials and Real World Data". Zurich. 2023-06-01
IO Biotech, Inc.. (6/1/23). "Press Release: IO Biotech Appoints Christine Richter, Ph.D., MBA, as Senior Vice President, Commercial and Program Lead". New York, NY. 2023-06-01
VarmX B.V.. (5/25/23). "Press Release: VarmX Raises €30 Million Series B2 Financing for IND Approval and Preparations for Pivotal Trial". Leiden. 2023-05-25
ElevateBio, LLC. (5/24/23). "Press Release: ElevateBio Announces $401 Million Series D Financing to Further Accelerate Growth". Waltham, MA. 2023-05-24
Council of European BioRegions (CEBR). (5/17/23). "Press Release: CEBR Appoints New President and Vice-President at Its Annual Meeting 2023". Stuttgart. 2023-05-17
Biocartis Group N.V.. (5/9/23). "Press Release: Biocartis and HiloProbe to Collaborate on Colorectal Cancer Test". Mechelen. 2023-05-09
Neogap Therapeutics AB. (5/4/23). "Press Release: Neogap and Cellerys Enter Collaboration Related to Phase II Study of a New Therapy for Multiple Sclerosis". 2023-05-04
va-Q-tec AG. (4/26/23). "Press Release: Sartorius and va-Q-tec Announce a Long-term Partnership for the Joint Development of Innovative Transport Systems for the Biopharmaceutical Industry". Würzburg & Göttingen. 2023-04-26
EniferBio Ltd.. (4/19/23). "Press Release: EniferBio raises €11M to Make Planet-friendly Fungal Protein from the By-products of food and agricultural processes". Espoo. 2023-04-19
Argenx SE. (4/17/23). "Press Release: Argenx and Genmab Enter Partnership to Advance Antibody Therapies in Immunology and Oncology". Amsterdam. 2023-04-17
Complement Therapeutics GmbH. (4/17/23). "Press Release: Complement Therapeutics Secures €72 Million in Series A Financing to Advance Novel Therapies Targeting Complement-Mediated Diseases". Munich. 2023-04-17
Alentis Therapeutics AG. (4/13/23). "Press Release: Alentis Therapeutics Closes $105 Million Series C Funding to Advance Transformational Medicines for Claudin-1". Basel. 2023-04-13
Mithra Pharmaceuticals S.A.. (4/4/23). "Press Release: Mithra Announces the Appointment of David H Solomon as Chief Executive Officer". Liège. 2023-04-04
Capitainer AB. (4/4/23). "Press Release: Capitainer Launches Fully Automated Sample Handler". Stockholm. 2023-04-04
AMSilk GmbH. (4/4/23). "Press Release: AMSilk Announces Extension of Series C Financing to EUR 54M". Munich. 2023-04-04
Adcendo ApS. (4/4/23). "Press Release: Adcendo ApS Announces Extension of Series A Financing to 82M EUR to Ensure Broad Development of its First-in-class ADC Pipeline". Copenhagen. 2023-04-04
AH Diagnostics A/S. (4/3/23). "Press Release: Helle Zacho Becomes the New CEO of the AH Diagnostics Group". 2023-04-03
PolyPeptide Group AG. (4/3/23). "Press Release: PolyPeptide Appoints Juan-José Gonzalez as CEO and Announces Change of CFO". Baar. 2023-04-03
EQT AB. (3/29/23). "Press Release: EQT Life Sciences Closes Dementia Fund at the Hard Cap". 2023-03-29
Alligator Bioscience AB. (3/22/23). "Press Release: Alligator Intends to Carry Out a 91 Percent Secured Rights Issue of Units of Approximately SEK 199 Million [Not for US, AU, et al.]". 2023-03-22
Biovian Oy. (3/16/23). "Press Release: Remedium Bio and Biovian Have Agreed to Collaborate on Remedium’s First-in-Class Disease Modifying AAV Gene Therapy for Osteoarthritis". 2023-03-16
Teitur Trophics ApS. (3/14/23). "Press Release: Teitur Trophics Raises EUR 28M in Series A Financing to Advance the Development and Treatment for Neurodegenerative Diseases". Aarhus. 2023-03-14
EQL Pharma AB. (3/13/23). "Press Release: EQL Pharma Recruits Carl Lindgren as Chief Business Development Officer". 2023-03-13
Oncopeptides AB. (3/8/23). "Press Release: Oncopeptides CSO Investigated for Violation of the Market Abuse Act". 2023-03-08
Oculis Holding AG. (3/3/23). "Press Release: Oculis Announces US Public Listing on NASDAQ". Lausanne & Zug. 2023-03-03
Bico Group AB. (2/27/23). "Press Release: Bico Introduces New Life Sciences Manufacturing Platform Integrating ABB Robotics Technology". 2023-02-27
Resalis Therapeutics S.r.l.. (2/22/23). "Press Release: Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases". Torino. 2023-02-22
Hemab ApS. (2/21/23). "Press Release: Hemab Therapeutics Announces $135M Series B Financing to Advance First Prophylactic Treatments for Underserved Bleeding and Thrombotic Disorders". Copenhagen & Boston, MA. 2023-02-21
Targovax ASA. (2/16/23). "Press Release: Targovax Announces Financing of up to NOK 300m Over Three Years to Advance Its Clinical Cancer Programs and Pre-clinical Circular RNA platform". Oslo. 2023-02-16
Biotage AB. (2/15/23). "Press Release: Biotage Strengthens Its Position as a Global Chromatography Leader with the Transformative Acquisition of Astrea Bioseparations". Uppsala. 2023-02-15
APK AG. (2/8/23). "Press Release: LyondellBasell and KIRKBI Invest in APK to Develop Recycling technology". Rotterdam, Billund & Merseburg. 2023-02-08
Novalis Biotech. (2/6/23). "Press Release: Novalis Biotech Invests in Rarity Bioscience’s Ultra Sensitive Genomics Technology". Uppsala. 2023-02-06
va-Q-tec AG. (1/30/23). "Press Release: Management and Supervisory Boards of va-Q-tec AG Recommend Acceptance of EQT Private Equity’s Voluntary Public Takeover Offer". Würzburg. 2023-01-30
Capitainer AB. (1/30/23). "Press Release: Capitainer Announces Collaboration with AstraZeneca". Stockholm. 2023-01-30
Rewind Therapeutics. (1/25/23). "Press Release: Rewind Therapeutics Raises Additional Funding and Adds Sunstone Life Science Ventures A/S as New Investor". Leuven. 2023-01-25
Alzinova AB. (1/24/23). "Press Release: Alzinova Recruits Business Development Director". 2023-01-24
AI Medical Technology. (1/24/23). "Press Release: AI Medical Technology Nets SEK10.8 Million to Accelerate Dermalyser AI-driven Diagnostic Support Tool for Skin Cancer". Stockholm. 2023-01-24
Sigrid Therapeutics AB. (1/16/23). "Press Release: Sigrid Therapeutics Raises further SEK10.6 Million in Oversubscribed Rights Issue for Accelerated SiPore Commercialization". Stockholm. 2023-01-16
TATAA Biocenter AB. (1/11/23). "Press Release: TATAA Biocenter Partners with Universal Sequencing Technology Corporation to Offer “Linked Long Read” Sequencing Services". 2023-01-11
Oncopeptides AB. (1/11/23). "Press Release: Oncopeptides Appoints Holger Lembrer as Chief Financial Officer". Stockholm. 2023-01-11
Evosep ApS. (1/9/23). "Press Release: Evosep Receives Strategic Investment from Novo Holdings A/S to Accelerate Its Effort on Clinical Proteomics". Odense. 2023-01-09
Ipsen S.A.. (1/9/23). "Press Release: Ipsen to Acquire Albireo Accelerating Growth in Rare Disease with Treatments for Several Pediatric Liver Diseases". Paris & Boston, MA. 2023-01-09
Agilent Technologies Inc.. (1/6/23). "Press Release: Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications". Santa Clara, CA & Marlborough, MA. 2023-01-06
Bactolife A/S. (1/4/23). "Press Release: Bactolife Appoints Sebastian Søderberg New CEO". Copenhagen. 2023-01-04
Oncopeptides AB. (1/4/23). "Press Release: Monica Shaw Appointed CEO of Oncopeptides – Jakob Lindberg Assumes Position as Chief Scientific Officer". Stockholm. 2023-01-04
Bico Group AB. (1/2/23). "Press Release: Bico Group Appoints New CFO". 2023-01-02
Affibody Medical AB. (12/23/22). "Press Release: Affibody Signs €20 Million Loan Agreement with the EIB to Finance the Development of Next Generation’s Biopharmaceuticals against Cancer and Inflammatory Diseases". Solna. 2022-12-23
European Invesmtent Bank (EIB). (12/23/22). "Press Release: Sweden – EIB Lends €20 Million to Biotech Company for Development of Biopharmaceuticals to Treat Cancer and Inflammatory Diseases". 2022-12-23
ADC Therapeutics S.A.. (12/21/22). "Press Release: ADC Therapeutics and Sobi Announce European Commission Approval of Zynlonta (loncastuximab tesirine) for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma". Lausanne. 2022-12-21
Nykode Therapeutics A/S. (12/19/22). "Press Release: Nykode Therapeutics and Richter-Helm BioLogics Announce Strategic Manufacturing Partnership". Oslo. 2022-12-19
Minervax ApS. (12/15/22). "Press Release: Minervax Announces 72M EUR Financing to Advance Development of Novel Vaccine against Group B Streptococcus". Copenhagen. 2022-12-15
Novozymes A/S. (12/12/22). "Press Release: Novozymes and Chr. Hansen to Combine and Create a Leading Global Biosolutions Partner [Not for US, CA, et al.]". Copenhagen. 2022-12-12
Sartorius AG. (12/8/22). "Press Release: Sartorius Agrees with Bico on Strategic Cooperation as well as a 10 Percent Capital Investment". Göttingen. 2022-12-08
Oncopeptides AB. (12/7/22). "Press Release: Oncopeptides Provides Update on Pepaxto US Marketing Authorization". Stockholm. 2022-12-07
MiGenTra GmbH. (11/29/22). "Press Release: Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa". 2022-11-29
Rarity Bioscience AB. (11/29/22). "Press Release: Rarity Bioscience Raises €2.5M in Seed Funding to Improve Cancer Care". Uppsala. 2022-11-29
Hemispherian AS. (11/24/22). "Press Release: Hemispherian Raises the First Tranche of a Series A to Fund the Development of Its Novel Cancer Therapeutics". Oslo. 2022-11-24
Novo Nordisk A/S. (11/22/22). "Press Release: Novo Nordisk Invests DKK 5.4 bn Danish Kroner in Expansion of Clinical Manufacturing Facilities in Bagsværd, Denmark". Bagsværd. 2022-11-22
Accession Therapeutics Ltd.. (11/21/22). "Press Release: Accession Therapeutics Raises £16.6m to Advance Potent Immunotherapies towards Clinical Trials". Oxford. 2022-11-21
European Invesmtent Bank (EIB). (11/18/22). "Press Release: Marjut Falkstedt Appointed as Chief Executive of the European Investment Fund". 2022-11-18
Sartorius AG. (11/11/22). "Press Release: Sartorius Successfully Places Schuldschein Loans with a Volume of 650 Million Euros". Göttingen. 2022-11-11
BC Platforms AG. (11/8/22). "Press Release: BC Platforms Announces USD 20 Million Growth Financing Led by Jolt Capital". 2022-11-08
OxSonics Therapeutics Ltd.. (11/7/22). "Press Release: Jérôme Marzinski Appointed as Chief Executive Officer". Oxford. 2022-11-07
Thermo Fisher Scientific Inc.. (10/31/22). "Press Release: Thermo Fisher Scientific to Acquire The Binding Site Group". Waltham, MA. 2022-10-31
Resolve Biosciences GmbH. (10/24/22). "Press Release: Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion to Meet Global Demand for Molecular Cartography Workflow". Monheim. 2022-10-24
FyoniBio GmbH. (10/20/22). "Press Release: FyoniBio and Strike Pharma Sign a Master Service Agreement Covering Cell Line Development for a Novel Bi-specific Therapeutic mAb". Berlin & Stockholm. 2022-10-20
Hemispherian AS. (10/19/22). "Press Release: Hemispherian Secures EUR 10M in Financing from the European Innovation Council (EIC) Accelerator Program". Oslo. 2022-10-19
Inversago Pharma Inc.. (10/19/22). "Press Release: Inversago Pharma Announces Appointment of Ed Mathers, BSc and Nanna Lüneborg, PhD, MBA to its Board of Directors". Montréal, QC. 2022-10-19
Inversago Pharma Inc.. (10/17/22). "Press Release: Inversago Pharma Raises $95 Million CAD in Series C Financing". Montréal, QC. 2022-10-17
Clinical Microbiomics A/S. (10/17/22). "Press Release: Clinical Microbiomics Acquire MS-Omics to Become Leading Multi-omics Provider for the Microbiome field". Copenhagen. 2022-10-17
Seventure Partners. (10/11/22). "Press Release: Clinical Microbiomics Set to Accelerate Its Expansion with EUR 10 Million Investment from Health for Life Capital II Managed by Seventure Partners". Paris & Copenhagen. 2022-10-11
Andera Partners. (10/10/22). "Press Release: Andera Partners Raises Its Largest Life Sciences Fund at €456M, Demonstrating the Attractiveness of Its Activity and of the Sector". Paris. 2022-10-10
IZB Martinsried. (10/7/22). "Press Release: Munich Life Science Pitch Day at the IZB. Eleven Teams Presented to 28 Life Science Investors with an Available Investment Volume of more than 20 Billion Euros". Martinsried. 2022-10-07
Sartorius AG. (9/30/22). "Press Release: Sartorius Completes Acquisition of Albumedix". Göttingen. 2022-09-30
Ventus Therapeutics, Inc.. (9/29/22). "Press Release: Ventus Therapeutics Enters Exclusive Development and License Agreement with Novo Nordisk for NLRP3 Inhibitor Program". Waltham, MA & Montréal, QC. 2022-09-29
1 2 3 4 5 6 7 8 9 10 11 12  next pagenext page


Picture EBD Group BIO-Europe 2023 Munich BEU23 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture BIO.NRW Greener Manufacutring Show 2023 Köln 650x300px

» top